Washington, DC – In response to a request from the U.S. Centers for Disease Control and Prevention, The Food and Drug Administration has issued an emergency use authorization for the intravenous (IV) investigational antiviral drug Peramivir, to be used in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are [...]